BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-25.42%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$713M
AUM Growth
+$713M
(-30%)
Cap. Flow
+$659K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Serina Therapeutics
SER
|
$8.96M |
Top Sells
| 1 |
Monster Beverage
MNST
|
$4.65M |
| 2 |
STAAR Surgical
STAA
|
$3.66M |
Sector Composition
| 1 | Healthcare | 55.12% |
| 2 | Consumer Staples | 32.32% |
| 3 | Industrials | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $343M | 48.1% | 10,740,630 -114,549 | -1% | -$3.66M |
|
|
2
Monster Beverage
MNST
$60.9B
| $230M | 32.32% | 4,679,308 -94,400 | -2% | -$4.65M |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $56.2M | 7.89% | 420,000 | – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $33.3M | 4.67% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $27.4M | 3.84% | 29,971,561 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $10.4M | 1.47% | 7,564,934 | – | – |
|
|
7
Serina Therapeutics
SER
$54.5M
| $8.96M | 1.26% | +2,997,156 | New | +$8.96M |
|
|
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $3.28M | 0.46% | 5,292,156 | – | – |
|
9
Delta Air Lines
DAL
$40.3B
| – | – | 0 | – | – |
|